About 2,170 results
Open links in new tab
FDA Approves First Stelara Biosimilar, Wezlana - Center for …
FDA Approves First Subcutaneous Infliximab Product - Center for …
Amgen Releases Positive Phase 3 Results for Stelara Biosimilar
FDA Approves First Denosumab Biosimilars - Center for Biosimilars
FDA Approves Semglee Insulin Glargine as First Interchangeable …
Center for Biosimilars®
FDA Approves Pfizer's Trastuzumab Biosimilar, Trazimera
Oncology | Clinical News & Insights - Center for Biosimilars
FDA Approves Fifth Pegfilgrastim Biosimilar, Fylnetra
Eli Lilly Launching Lower-Priced Authorized Generic of Its Insulin …